Rifaximin for Treatment of Small Bowel Bacterial Overgrowth
Open Access
- 6 September 2018
- journal article
- Published by Lupine Publishers LLC in Current Trends in Gastroenterology and Hepatology
- Vol. 1 (3) , 1-4
- https://doi.org/10.32474/ctgh.2018.01.000115
Abstract
Small intestinal bacterial overgrowth (SIBO) is characterized by excessive bacteria in the small intestine. The upper small intestine is relatively sterile because of the combined effects of normal peristalsis and the antibacterial action of bile acids.Keywords
This publication has 0 references indexed in Scilit: